D.E. Shaw & Co’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$644K Sell
143,201
-88,562
-38% -$387K ﹤0.01% 3717
2025
Q4
$1.11M Buy
231,763
+41,811
+22% +$188K ﹤0.01% 3463
2025
Q3
$862K Buy
189,952
+149,252
+367% +$548K ﹤0.01% 3547
2025
Q2
$126K Buy
+40,700
New +$135K ﹤0.01% 4107
2022
Q2
Sell
-19,698
Closed -$59K 5294
2022
Q1
$59K Sell
19,698
-3,202
-14% -$9.8K ﹤0.01% 5106
2021
Q4
$89K Buy
+22,900
New +$89K ﹤0.01% 5089
2019
Q3
Sell
-19,300
Closed -$40K 3769
2019
Q2
$40K Sell
19,300
-28,747
-60% -$73.5K ﹤0.01% 3598
2019
Q1
$172K Hold
48,047
﹤0.01% 3423
2018
Q4
$184K Sell
48,047
-12,509
-21% -$61.6K ﹤0.01% 3564
2018
Q3
$572K Sell
60,556
-409,952
-87% -$4.07M ﹤0.01% 3030
2018
Q2
$3.44M Sell
470,508
-239,954
-34% -$1.43M 0.01% 1807
2018
Q1
$3.55M Sell
710,462
-495,663
-41% -$2.62M 0.01% 1643
2017
Q4
$6.09M Sell
1,206,125
-547,980
-31% -$3.21M 0.01% 1358
2017
Q3
$10.9M Buy
1,754,105
+19,576
+1% +$83.7K 0.02% 895
2017
Q2
$6.24M Sell
1,734,529
-12,573
-0.7% -$43.3K 0.01% 1184
2017
Q1
$5.68M Buy
1,747,102
+12,499
+0.7% +$34.7K 0.01% 1205
2016
Q4
$4.25M Buy
1,734,603
+13,622
+0.8% +$39.6K 0.01% 1455
2016
Q3
$5.92M Sell
1,720,981
-20,914
-1% -$81.7K 0.01% 1189
2016
Q2
$6.06M Buy
1,741,895
+30,326
+2% +$128K 0.01% 1165
2016
Q1
$7.07M Sell
1,711,569
-159,891
-9% -$571K 0.02% 1057
2015
Q4
$8.33M Buy
1,871,460
+14,384
+0.8% +$78.8K 0.02% 1056
2015
Q3
$11.3M Sell
1,857,076
-157,536
-8% -$1.4M 0.02% 894
2015
Q2
$23.9M Buy
2,014,612
+332,712
+20% +$5.06M 0.05% 567
2015
Q1
$29.4M Buy
1,681,900
+1,625,221
+2,867% +$33.3M 0.06% 468
2014
Q4
$859K Buy
56,679
+45,773
+420% +$790K ﹤0.01% 2946
2014
Q3
$231K Buy
+10,906
New +$178K ﹤0.01% 3822
2014
Q2
Hold
0
4134
2014
Q1
Hold
0
4228

Other funds holding ABUS